期刊文献+

猪心包塑形三瓣叶管道的制备及其体外评价

Porcine pericardium three valve conduit preparation and in vitro evaluation
下载PDF
导出
摘要 目的制备出猪心包塑形三瓣叶管道,在体外条件下检测其抗反流性、力学强度、抗酶降解能力、血液相容性和免疫原性,并与牛颈静脉三瓣管道相比较,以探讨其临床应用前景。方法以心包制备三瓣叶管道共计12根,并取与猪心包三瓣叶管道直径大致相同的带瓣牛颈静脉8根,通过 HE染色、Masson 三色染色和 Elastica-vall-Gienson 染色粗略了解管道的免疫原性;以蠕动泵模拟心脏搏动以评价管道的抗反流特性;计算最大拉伸强度和断裂伸长率来评价力学性能;以胶原蛋白酶降解管道来比较抗酶降解的能力;以体外溶血率比较管道的血液相容性。结果①牛颈静脉管道组(A 组)的溶解百分比为30.12%±2.37%,猪心包管道组(B 组)的溶解百分比为36.27%±4.62%;②蠕动泵转数为30 r/min 时,A 组反流比率为24.17%±10.53%,B 组为18.91%±13.48%,50 r/min 时,A 组反流比率为47.6%±9.8%,B 组为44.9%±9.64%,70 r/min 时,A 组反流率为57.2%±10.7%,B 组为53.3%±19.4%;③横轴血管片最大拉伸强度分别为 A 组(2.82±1.2)N /mm2、B 组为(11.84±4.69)N /mm2,断裂伸长率分别为 A 组78.43%±19.24%、B 组49.26%±11.27%,纵轴血管片最大拉伸强度 A 组(1.92±1.25)N /mm2、B 组(13.29±5.08)N /mm2,纵轴断裂延伸率分别为 A 组77.07%±18.74%、B组49.72%±15.85%;④A 组溶血率为0.14%±0.465%,B 组溶血率0.0975%±0.445%。结论自制的猪心包带瓣管道,大体和微观形态无明显改变,在抗反流性能上与牛颈静脉无明显差异,机械性能明显优于牛颈静脉,短期抗酶降解能力较牛颈静脉略有不足,免疫原性上优于牛颈静脉管道,具备良好的血液相容性。 Objective Prepared porcine pericardium three valve conduit,and in vitro conditions,de-tected the anti-reflux,mechanical strength,resistance to enzyme degradation ability,blood compatibility and immunogenicity,and compared with bovine jugular vein,in order to discuss the clinical application.Methods Porcine pericardium sewn three valve conduit a total of 12 pipelines.Take the same conduit diameter valve bo-vine jugular vein a total of 8,doing the HE,Masson and Elastica-vall-Gienson stained light microscopy test to observe the changes in morphology and sketchy understanding conduit immunogenicity,use peristaltic pump simulating heart throb to evaluate the anti-reflux.Doing a Villa extended experiment to draw the stress-strain curves,then calculating the slope k,evaluate the mechanical properties,degrading them in the circumstance of collagen type I to understand the capacity of resistance to enzymatic degradation,detecting the rate of haematol-ysis to see whether they fit the principal of hemolytic compatibility.Results (1)Dissolved percentagethe for group A 30.12% ±2.37%,group B 36.27% ±4.62%;(2)Peristaltic pump for 30 r/min,A group of reflux ratio for 24.17% ±10.53%,as group B 18.91% ±13.48%,;50 r/min,A group of reflux ratio for 47.6%±9.8%,group B 44.9% ±9.64%;70 r/min,A group for 57.2% ±10.7%,group B 53.3% ±19.4%;(3)The horizontal axis of the maximum tensile strength of vascular piece for A group(2.82 ±1.2)N /mm2 , group B(11.84 ±4.69)N /mm2 ,elongation ratio at break for A group 78.43% ±19.24%,group B 49.26%±11.27%,the vertical axis of maximum tensile strength of vascular piece for group A(1.92 ±1.25)N /mm2 , group B(13.29 ±5.08)N /mm2 ,elongation ratio for group A 77.07% ±18.74%,group B 49.72% ±15.85%;(4)Hemolysis rate for group A 0.14% ±0.465%,group B 0.0975% ±0.445%. Conclusion Porcine pericardium three valve conduit had no significant difference in morphology when compared with the bo-vine jugular vein pipeline.In resistance to reflux performance,porcine pericardium three valve conduits and bo-vine jugular veins are no obvious difference,mechanical performance and the immunogenicity better than bovine jugular vein,short-term resistance to enzyme degradation ability is insufficient slightly.They all have a good blood compatibility.
出处 《临床小儿外科杂志》 CAS 2014年第6期479-483,共5页 Journal of Clinical Pediatric Surgery
基金 国家自然科学基金项目(项目号:30872701)
关键词 心包 颈静脉 心脏瓣膜 心脏病 Pericardium Swine Jugular Veina Cattle Heart Valves Heart Diseases
  • 相关文献

参考文献2

二级参考文献24

  • 1朱军,周光萱,代礼,王艳萍,梁娟,缪蕾.1996~2000年全国围产期先天性心脏病发生率的分析[J].四川大学学报(医学版),2004,35(6):875-877. 被引量:63
  • 2袁雪,王惠珊,闫淑娟,王晓华,朱雪娜,卢秀英.10665名儿童先天性心脏病发病状况监测结果和环境危险因素分析[J].中国妇幼保健,2006,21(6):781-783. 被引量:57
  • 3黄宏琳,何舒杰,金凌晖.新生儿及小婴儿先天性心脏病分析[J].中国优生与遗传杂志,2006,14(6):96-96. 被引量:6
  • 4Kim W S, Vacanti C A,Upton J, et al. Bone defect repair with tissue-engineered cartilage. Plast Recontr Surg, 1994,94:580-584.
  • 5Vacanti C A, Paige K T, Kim W S, et al. Experimental tracheal replacement using tissue-engineered cartilag. J Pediatr Surg, 1994,29:201-204.
  • 6Cao Y L, Vacanti J P, Paige K T, et al. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg, 1997,100:297-302.
  • 7Peppas H A, Lanser R. New challenge in biomaterials.Science, 1994,263:1715-1720.
  • 8Freed L E, Langer R, Martin I, et al. Tissue engineering of cartilage in space. Pro Natl Acad Sci USA, 1997,94:1385-1389.
  • 9Eiselt P, Kims B S, Chacko B, et al. Development of technologies aiding large-tissue engineering. Biotechnol Prog, 1998,14:134-140.
  • 10Faulkner D M, Sutton S T, Hesford J D, et al. A new stable pluronic F68 gel carrier for antibiotics in contaminated wound treatment. Am J Emerg Med, 1997,15:20-24.

共引文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部